-
1
-
-
77955279420
-
Mortality results from the Goteborg randomised population-based prostate-cancer screening trial
-
Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, et al. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 2010;11:725-32.
-
(2010)
Lancet Oncol
, vol.11
, pp. 725-732
-
-
Hugosson, J.1
Carlsson, S.2
Aus, G.3
Bergdahl, S.4
Khatami, A.5
Lodding, P.6
-
2
-
-
0037319283
-
Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy
-
DOI 10.1016/S0090-4295(02)02268-9
-
Freedland SJ, Sutter ME, Dorey F, Aronson WJ. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. Urology 2003;61:365-9. (Pubitemid 36206534)
-
(2003)
Urology
, vol.61
, Issue.2
, pp. 365-369
-
-
Freedland, S.J.1
Sutter, M.E.2
Dorey, F.3
Aronson, W.J.4
-
3
-
-
33745184874
-
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
-
Roach M III, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006;65:965-74.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 965-974
-
-
Roach III, M.1
Hanks, G.2
Thames Jr., H.3
Schellhammer, P.4
Shipley, W.U.5
Sokol, G.H.6
-
4
-
-
9644279380
-
Androgen deprivation therapy for prostate cancer: Current status and future prospects
-
DOI 10.1002/pros.20115
-
Miyamoto H, Messing EM, Chang C. Androgen deprivation therapy for prostate cancer: current status and future prospects. Prostate 2004;61:332-53. (Pubitemid 39571710)
-
(2004)
Prostate
, vol.61
, Issue.4
, pp. 332-353
-
-
Miyamoto, H.1
Messing, E.M.2
Chang, C.3
-
5
-
-
0037829212
-
The pleiotropic functions of the Y-box-binding protein, YB-1
-
DOI 10.1002/bies.10300
-
Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M. The pleiotropic functions of the Y-box-binding protein, YB-1. BioEssays 2003;25:691-8. (Pubitemid 36850797)
-
(2003)
BioEssays
, vol.25
, Issue.7
, pp. 691-698
-
-
Kohno, K.1
Izumi, H.2
Uchiumi, T.3
Ashizuka, M.4
Kuwano, M.5
-
6
-
-
0037648903
-
The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies
-
DOI 10.1111/j.1349-7006.2003.tb01344.x
-
Kuwano M, Uchiumi T, Hayakawa H, Ono M, Wada M, Izumi H, et al. The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies. Cancer Sci 2003;94:9-14. (Pubitemid 36575851)
-
(2003)
Cancer Science
, vol.94
, Issue.1
, pp. 9-14
-
-
Kuwano, M.1
Uchiumi, T.2
Hayakawa, H.3
Ono, M.4
Wada, M.5
Izumi, H.6
Kohno, K.7
-
7
-
-
27544467567
-
Transcription factors and drug resistance
-
DOI 10.1016/j.ejca.2005.08.007, PII S0959804905007069, Transcription Factors in Cancer
-
Kohno K, Uchiumi T, Niina I, Wakasugi T, Igarashi T, Momii Y, et al. Transcription factors and drug resistance. Eur J Cancer 2005;41:2577-86. (Pubitemid 41540632)
-
(2005)
European Journal of Cancer
, vol.41
, Issue.16
, pp. 2577-2586
-
-
Kohno, K.1
Uchiumi, T.2
Niina, I.3
Wakasugi, T.4
Igarashi, T.5
Momii, Y.6
Yoshida, T.7
Matsuo, K.-I.8
Miyamoto, N.9
Izumi, H.10
-
8
-
-
77950849807
-
Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance
-
To K, Fotovati A, Reipas KM, Law JH, Hu K, Wang J, et al. Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. Cancer Res 2010;70:2840-51.
-
(2010)
Cancer Res
, vol.70
, pp. 2840-2851
-
-
To, K.1
Fotovati, A.2
Reipas, K.M.3
Law, J.H.4
Hu, K.5
Wang, J.6
-
9
-
-
67649986048
-
The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1
-
Astanehe A, Finkbeiner MR, Hojabrpour P, To K, Fotovati A, Shadeo A, et al. The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1. Oncogene 2009;28:2406-18.
-
(2009)
Oncogene
, vol.28
, pp. 2406-2418
-
-
Astanehe, A.1
Finkbeiner, M.R.2
Hojabrpour, P.3
To, K.4
Fotovati, A.5
Shadeo, A.6
-
10
-
-
62649165025
-
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells
-
Finkbeiner MR, Astanehe A, To K, Fotovati A, Davies AH, Zhao Y, et al. Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells. Oncogene 2009;28:1421-31.
-
(2009)
Oncogene
, vol.28
, pp. 1421-1431
-
-
Finkbeiner, M.R.1
Astanehe, A.2
To, K.3
Fotovati, A.4
Davies, A.H.5
Zhao, Y.6
-
11
-
-
65349116534
-
Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition
-
Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink D, et al. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 2009;15:402-15.
-
(2009)
Cancer Cell
, vol.15
, pp. 402-415
-
-
Evdokimova, V.1
Tognon, C.2
Ng, T.3
Ruzanov, P.4
Melnyk, N.5
Fink, D.6
-
12
-
-
9444259316
-
The role of nuclear Y-box binding protein 1 as a global marker in drug resistance
-
Kuwano M, Oda Y, Izumi H, Yang SJ, Uchiumi T, Iwamoto Y, et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. Mol Cancer Ther 2004;3:1485-92. (Pubitemid 39562593)
-
(2004)
Molecular Cancer Therapeutics
, vol.3
, Issue.11
, pp. 1485-1492
-
-
Kuwano, M.1
Oda, Y.2
Izumi, H.3
Yang, S.-J.4
Uchiumi, T.5
Iwamoto, Y.6
Toi, M.7
Fujii, T.8
Yamana, H.9
Kinoshita, H.10
Kamura, T.11
Tsuneyoshi, M.12
Yasumoto, K.13
Kohno, K.14
-
13
-
-
1942539331
-
YB-1 Is Upregulated during Prostate Cancer Tumor Progression and Increases P-Glycoprotein Activity
-
DOI 10.1002/pros.20023
-
Gimenez-Bonafe P, Fedoruk MN, Whitmore TG, Akbari M, Ralph JL, Ettinger S, et al. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity. Prostate 2004;59:337-49. (Pubitemid 38509767)
-
(2004)
Prostate
, vol.59
, Issue.3
, pp. 337-349
-
-
Gimenez-Bonafe, P.1
Fedoruk, M.N.2
Whitmore, T.G.3
Akbari, M.4
Ralph, J.L.5
Ettinger, S.6
Gleave, M.E.7
Nelson, C.C.8
-
14
-
-
80052161751
-
Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression
-
Shiota M, Takeuchi A, Song Y, Yokomizo A, Kashiwagi E, Uchiumi T, et al. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression. Endocr Relat Cancer 2011;18:505-17.
-
(2011)
Endocr Relat Cancer
, vol.18
, pp. 505-517
-
-
Shiota, M.1
Takeuchi, A.2
Song, Y.3
Yokomizo, A.4
Kashiwagi, E.5
Uchiumi, T.6
-
15
-
-
0142091357
-
Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway
-
DOI 10.1073/pnas.2135336100
-
Bader AG, Felts KA, Jiang N, Chang HW, Vogt PK. Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway. Proc Natl Acad Sci U S A 2003;100:12384-9. (Pubitemid 37271569)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.21
, pp. 12384-12389
-
-
Bader, A.G.1
Felts, K.A.2
Jiang, N.3
Chang, H.W.4
Vogt, P.K.5
-
16
-
-
55349110263
-
Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice
-
Lee C, Dhillon J, Wang MY, Gao Y, Hu K, Park E, et al. Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice. Cancer Res 2008;68:8661-6.
-
(2008)
Cancer Res
, vol.68
, pp. 8661-8666
-
-
Lee, C.1
Dhillon, J.2
Wang, M.Y.3
Gao, Y.4
Hu, K.5
Park, E.6
-
17
-
-
84867399412
-
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition
-
Astanehe A, Finkbeiner MR, Krzywinski M, Fotovati A, Dhillon J, Berquin IM, et al. MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition. Oncogene 2012;31:4434-46.
-
(2012)
Oncogene
, vol.31
, pp. 4434-4446
-
-
Astanehe, A.1
Finkbeiner, M.R.2
Krzywinski, M.3
Fotovati, A.4
Dhillon, J.5
Berquin, I.M.6
-
18
-
-
25844447793
-
Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3beta and repression of the human VEGF promoter
-
DOI 10.1016/j.febslet.2005.08.075, PII S0014579305010987
-
Coles LS, Lambrusco L, Burrows J, Hunter J, Diamond P, Bert AG, et al. Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3beta and repression of the human VEGF promoter. FEBS Lett 2005;579:5372-8. (Pubitemid 41395158)
-
(2005)
FEBS Letters
, vol.579
, Issue.24
, pp. 5372-5378
-
-
Coles, L.S.1
Lambrusco, L.2
Burrows, J.3
Hunter, J.4
Diamond, P.5
Bert, A.G.6
Vadas, M.A.7
Goodall, G.J.8
-
19
-
-
78650697735
-
Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells
-
Jurchott K, Kuban RJ, Krech T, Bluthgen N, Stein U, Walther W, et al. Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells. PLoS Genet 2010;6:e1001231.
-
(2010)
PLoS Genet
, vol.6
-
-
Jurchott, K.1
Kuban, R.J.2
Krech, T.3
Bluthgen, N.4
Stein, U.5
Walther, W.6
-
20
-
-
62649113168
-
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
-
Stratford AL, Fry CJ, Desilets C, Davies AH, Cho YY, Li Y, et al. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells. Breast Cancer Res 2008;10:R99.
-
(2008)
Breast Cancer Res
, vol.10
-
-
Stratford, A.L.1
Fry, C.J.2
Desilets, C.3
Davies, A.H.4
Cho, Y.Y.5
Li, Y.6
-
21
-
-
84860389438
-
Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation
-
Toulany M, Schickfluss TA, Eicheler W, Kehlbach R, Schittek B, Rodemann HP. Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation. Breast Cancer Res 2011;13:R28.
-
(2011)
Breast Cancer Res
, vol.13
-
-
Toulany, M.1
Schickfluss, T.A.2
Eicheler, W.3
Kehlbach, R.4
Schittek, B.5
Rodemann, H.P.6
-
22
-
-
34547209343
-
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
-
McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007;1773:1263-84.
-
(2007)
Biochim Biophys Acta
, vol.1773
, pp. 1263-1284
-
-
McCubrey, J.A.1
Steelman, L.S.2
Chappell, W.H.3
Abrams, S.L.4
Wong, E.W.5
Chang, F.6
-
23
-
-
34248591612
-
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
-
DOI 10.1038/sj.onc.1210422, PII 1210422
-
Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007;26:3291-310. (Pubitemid 46763022)
-
(2007)
Oncogene
, vol.26
, Issue.22
, pp. 3291-3310
-
-
Roberts, P.J.1
Der, C.J.2
-
24
-
-
33749253906
-
Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations
-
discussion 1109-1110
-
Burger M, Denzinger S, Hammerschmied C, Tannapfel A, Maderstorfer A, Wieland WF, et al. Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations. Eur Urol 2006;50:1102-9; discussion 1109-1110.
-
(2006)
Eur Urol
, vol.50
, pp. 1102-1109
-
-
Burger, M.1
Denzinger, S.2
Hammerschmied, C.3
Tannapfel, A.4
Maderstorfer, A.5
Wieland, W.F.6
-
25
-
-
74449089780
-
Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression
-
Shiota M, Yokomizo A, Tada Y, Inokuchi J, Kashiwagi E, Masubuchi D, et al. Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression. Oncogene 2010;29:237-50.
-
(2010)
Oncogene
, vol.29
, pp. 237-250
-
-
Shiota, M.1
Yokomizo, A.2
Tada, Y.3
Inokuchi, J.4
Kashiwagi, E.5
Masubuchi, D.6
-
26
-
-
84055182512
-
Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancer
-
Shiota M, Zoubeidi A, Kumano M, Beraldi E, Naito S, Nelson CC, et al. Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancer. Mol Cancer Res 2011;9:1755-66.
-
(2011)
Mol Cancer Res
, vol.9
, pp. 1755-1766
-
-
Shiota, M.1
Zoubeidi, A.2
Kumano, M.3
Beraldi, E.4
Naito, S.5
Nelson, C.C.6
-
27
-
-
29344434259
-
Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel
-
DOI 10.1158/1078-0432.CCR-05-0945
-
Fujita T, Ito K, Izumi H, Kimura M, Sano M, Nakagomi H, et al. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel. Clin Cancer Res 2005;11:8837-44. (Pubitemid 43005936)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.24
, pp. 8837-8844
-
-
Fujita, T.1
Ito, K.-I.2
Izumi, H.3
Kimura, M.4
Sano, M.5
Nakagomi, H.6
Maeno, K.7
Hama, Y.8
Shingu, K.9
Tsuchiya, S.-I.10
Kohno, K.11
Fujimori, M.12
-
28
-
-
0031915998
-
Prognostic and predictive factors in breast cancer by immunohistochemical analysis
-
Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998;11:155-68. (Pubitemid 28144151)
-
(1998)
Modern Pathology
, vol.11
, Issue.2
, pp. 155-168
-
-
Allred, D.C.1
Harvey, J.M.2
Berardo, M.3
Clark, G.M.4
-
29
-
-
84555189440
-
Regulation and function of the RSK family of protein kinases
-
Romeo Y, Zhang X, Roux PP. Regulation and function of the RSK family of protein kinases. Biochem J 2012;441:553-69.
-
(2012)
Biochem J
, vol.441
, pp. 553-569
-
-
Romeo, Y.1
Zhang, X.2
Roux, P.P.3
-
30
-
-
33744908818
-
Y-box binding protein 1: Providing a new angle on translational regulation
-
Evdokimova V, Ovchinnikov LP, Sorensen PH. Y-box binding protein 1: providing a new angle on translational regulation. Cell Cycle 2006;5:1143-7. (Pubitemid 43845371)
-
(2006)
Cell Cycle
, vol.5
, Issue.11
, pp. 1143-1147
-
-
Evdokimova, V.1
Ovchinnikov, L.P.2
Sorensen, P.H.B.3
-
31
-
-
80052065124
-
YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification
-
Davies AH, Barrett I, Pambid MR, Hu K, Stratford AL, Freeman S, et al. YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification. Oncogene 2011;30:3649-60.
-
(2011)
Oncogene
, vol.30
, pp. 3649-3660
-
-
Davies, A.H.1
Barrett, I.2
Pambid, M.R.3
Hu, K.4
Stratford, A.L.5
Freeman, S.6
-
32
-
-
40449092491
-
Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers
-
DOI 10.1158/0008-5472.CAN-07-2362
-
Fujii T, Kawahara A, Basaki Y, Hattori S, Nakashima K, Nakano K, et al. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers. Cancer Res 2008;68:1504-12. (Pubitemid 351346859)
-
(2008)
Cancer Research
, vol.68
, Issue.5
, pp. 1504-1512
-
-
Fujii, T.1
Kawahara, A.2
Basaki, Y.3
Hattori, S.4
Nakashima, K.5
Nakano, K.6
Shirouzu, K.7
Kohno, K.8
Yanagawa, T.9
Yamana, H.10
Nishio, K.11
Ono, M.12
Kuwano, M.13
Kage, M.14
-
33
-
-
84865513836
-
Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer
-
Hyogotani A, Ito KI, Yoshida K, Izumi H, Kohno K, Amano J. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer. Clin Lung Cancer 2012;13:375-84.
-
(2012)
Clin Lung Cancer
, vol.13
, pp. 375-384
-
-
Hyogotani, A.1
Ito, K.I.2
Yoshida, K.3
Izumi, H.4
Kohno, K.5
Amano, J.6
-
34
-
-
78649869697
-
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1
-
Kalra J, Sutherland BW, Stratford AL, Dragowska W, Gelmon KA, Dedhar S, et al. Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1. Oncogene 2010;29:6343-56.
-
(2010)
Oncogene
, vol.29
, pp. 6343-6356
-
-
Kalra, J.1
Sutherland, B.W.2
Stratford, A.L.3
Dragowska, W.4
Gelmon, K.A.5
Dedhar, S.6
-
35
-
-
69549091683
-
Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer
-
Kashihara M, Azuma K, Kawahara A, Basaki Y, Hattori S, Yanagawa T, et al. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer. J Thorac Oncol 2009;4:1066-74.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 1066-1074
-
-
Kashihara, M.1
Azuma, K.2
Kawahara, A.3
Basaki, Y.4
Hattori, S.5
Yanagawa, T.6
-
36
-
-
36549075549
-
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy
-
Stratford AL, Habibi G, Astanehe A, Jiang H, Hu K, Park E, et al. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy. Breast Cancer Res 2007;9:R61.
-
(2007)
Breast Cancer Res
, vol.9
-
-
Stratford, A.L.1
Habibi, G.2
Astanehe, A.3
Jiang, H.4
Hu, K.5
Park, E.6
-
37
-
-
33646394318
-
Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2
-
Wu J, Lee C, Yokom D, Jiang H, Cheang MC, Yorida E, et al. Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2. Cancer Res 2006;66:4872-9.
-
(2006)
Cancer Res
, vol.66
, pp. 4872-4879
-
-
Wu, J.1
Lee, C.2
Yokom, D.3
Jiang, H.4
Cheang, M.C.5
Yorida, E.6
-
38
-
-
67649836789
-
Y-box protein 1 stimulates mesangial cell proliferation via activation of ERK1/2
-
Feng Q, Huang S, Zhang A, Chen Q, Guo X, Chen R, et al. Y-box protein 1 stimulates mesangial cell proliferation via activation of ERK1/2. Nephron Exp Nephrol 2009;113:e16-25.
-
(2009)
Nephron Exp Nephrol
, vol.113
-
-
Feng, Q.1
Huang, S.2
Zhang, A.3
Chen, Q.4
Guo, X.5
Chen, R.6
-
39
-
-
84883488837
-
YB-1 (YBX1) does not bind to Y/CCAAT boxes in vivo
-
Nov 19. [Epub ahead of print]
-
Dolfini D, Mantovani R. YB-1 (YBX1) does not bind to Y/CCAAT boxes in vivo. Oncogene 2012 Nov 19. [Epub ahead of print].
-
(2012)
Oncogene
-
-
Dolfini, D.1
Mantovani, R.2
-
40
-
-
1342301559
-
Conferring specificity on the ubiquitous Raf/MEK signalling pathway
-
DOI 10.1038/sj.bjc.6601488
-
O'Neill E, Kolch W. Conferring specificity on the ubiquitous Raf/MEK signalling pathway. Br J Cancer 2004;90:283-8. (Pubitemid 38250615)
-
(2004)
British Journal of Cancer
, vol.90
, Issue.2
, pp. 283-288
-
-
O'Neill, E.1
Kolch, W.2
-
41
-
-
51649125641
-
RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo
-
Bessard A, Fremin C, Ezan F, Fautrel A, Gailhouste L, Baffet G. RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo. Oncogene 2008;27:5315-25.
-
(2008)
Oncogene
, vol.27
, pp. 5315-5325
-
-
Bessard, A.1
Fremin, C.2
Ezan, F.3
Fautrel, A.4
Gailhouste, L.5
Baffet, G.6
-
42
-
-
34447329284
-
Distinct functions for ERKs?
-
Lloyd AC. Distinct functions for ERKs? J Biol 2006;5:13.
-
(2006)
J Biol
, vol.5
, pp. 13
-
-
Lloyd, A.C.1
-
43
-
-
33845904217
-
ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially
-
Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, Brambilla R. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 2006;5:14.
-
(2006)
J Biol
, vol.5
, pp. 14
-
-
Vantaggiato, C.1
Formentini, I.2
Bondanza, A.3
Bonini, C.4
Naldini, L.5
Brambilla, R.6
-
44
-
-
66149147100
-
Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth
-
Shiota M, Izumi H, Tanimoto A, Takahashi M, Miyamoto N, Kashiwagi E, et al. Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth. Cancer Res 2009;69:3148-56.
-
(2009)
Cancer Res
, vol.69
, pp. 3148-3156
-
-
Shiota, M.1
Izumi, H.2
Tanimoto, A.3
Takahashi, M.4
Miyamoto, N.5
Kashiwagi, E.6
-
45
-
-
84855577580
-
Antioxidant therapy alleviates oxidative stress by androgen deprivation and prevents conversion from androgen dependent to castration resistant prostate cancer
-
Shiota M, Song Y, Takeuchi A, Yokomizo A, Kashiwagi E, Kuroiwa K, et al. Antioxidant therapy alleviates oxidative stress by androgen deprivation and prevents conversion from androgen dependent to castration resistant prostate cancer. J Urol 2012;187:707-14.
-
(2012)
J Urol
, vol.187
, pp. 707-714
-
-
Shiota, M.1
Song, Y.2
Takeuchi, A.3
Yokomizo, A.4
Kashiwagi, E.5
Kuroiwa, K.6
-
46
-
-
0029904681
-
Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis
-
Loda M, Capodieci P, Mishra R, Yao H, Corless C, Grigioni W, et al. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am J Pathol 1996;149:1553-64. (Pubitemid 26363962)
-
(1996)
American Journal of Pathology
, vol.149
, Issue.5
, pp. 1553-1564
-
-
Loda, M.1
Capodieci, P.2
Mishra, R.3
Yao, H.4
Corless, C.5
Grigioni, W.6
Wang, Y.7
Magi-Galluzzi, C.8
Stork, P.J.S.9
-
47
-
-
0036235788
-
Regulation of proliferation/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate
-
DOI 10.1053/hupa.2002.32227
-
Royuela M, Arenas MI, Bethencourt FR, Sanchez-Chapado M, Fraile B, Paniagua R. Regulation of proliferation/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate. Hum Pathol 2002;33:299-306. (Pubitemid 34461463)
-
(2002)
Human Pathology
, vol.33
, Issue.3
, pp. 299-306
-
-
Royuela, M.1
Arenas, M.I.2
Bethencourt, F.R.3
Fraile, B.4
Paniagua, R.5
-
48
-
-
0033555967
-
Activation of mitogen-activated protein kinase associated with prostate cancer progression
-
Gioeli D, Mandell JW, Petroni GR, Frierson HF Jr, Weber MJ. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 1999;59:279-84. (Pubitemid 29048852)
-
(1999)
Cancer Research
, vol.59
, Issue.2
, pp. 279-284
-
-
Gioeli, D.1
Mandell, J.W.2
Petroni, G.R.3
Frierson Jr., H.F.4
Weber, M.J.5
-
49
-
-
0032819983
-
Activation of extracellular signal-regulated kinase in human prostate cancer
-
DOI 10.1016/S0022-5347(05)68354-1
-
Price DT, Della Rocca G, Guo C, Ballo MS, Schwinn DA, Luttrell LM. Activation of extracellular signal-regulated kinase in human prostate cancer. J Urol 1999;162:1537-42. (Pubitemid 29428632)
-
(1999)
Journal of Urology
, vol.162
, Issue.4
, pp. 1537-1542
-
-
Price, D.T.1
Della, R.G.2
Guo, C.3
Ballo, M.S.4
Schwinn, D.A.5
Luttrell, L.M.6
-
50
-
-
79958098599
-
Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer
-
Mukherjee R, McGuinness DH, McCall P, Underwood MA, Seywright M, Orange C, et al. Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer. Br J Cancer 2011;104:1920-8.
-
(2011)
Br J Cancer
, vol.104
, pp. 1920-1928
-
-
Mukherjee, R.1
McGuinness, D.H.2
McCall, P.3
Underwood, M.A.4
Seywright, M.5
Orange, C.6
-
51
-
-
39149103407
-
Twist promotes tumor cell growth through YB-1 expression
-
DOI 10.1158/0008-5472.CAN-07-2981
-
Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, Kidani A, et al. Twist promotes tumor cell growth through YB-1 expression. Cancer Res 2008;68:98-105. (Pubitemid 351380110)
-
(2008)
Cancer Research
, vol.68
, Issue.1
, pp. 98-105
-
-
Shiota, M.1
Izumi, H.2
Onitsuka, T.3
Miyamoto, N.4
Kashiwagi, E.5
Kidani, A.6
Yokomizo, A.7
Naito, S.8
Kohno, K.9
-
52
-
-
0037379794
-
SAPK
-
Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38 (SAPK). Cancer Res 2003;63:1684-95. (Pubitemid 36373662)
-
(2003)
Cancer Research
, vol.63
, Issue.7
, pp. 1684-1695
-
-
Aguirre-Ghiso, J.A.1
Estrada, Y.2
Liu, D.3
Ossowski, L.4
-
53
-
-
84859416889
-
Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells
-
Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J, et al. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res 2012;72:1878-89.
-
(2012)
Cancer Res
, vol.72
, pp. 1878-1889
-
-
Mulholland, D.J.1
Kobayashi, N.2
Ruscetti, M.3
Zhi, A.4
Tran, L.M.5
Huang, J.6
-
54
-
-
33749254070
-
Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer
-
DOI 10.1073/pnas.0606836103
-
Gao H, Ouyang X, Banach-Petrosky WA, Gerald WL, Shen MM, Abate-Shen C. Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proc Natl Acad Sci U S A 2006;103:14477-82. (Pubitemid 44484775)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.39
, pp. 14477-14482
-
-
Gao, H.1
Ouyang, X.2
Banach-Petrosky, W.A.3
Gerald, W.L.4
Shen, M.M.5
Abate-Shen, C.6
-
55
-
-
51349111250
-
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
-
Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, Gao H, et al. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. J Clin Invest 2008;118:3051-64.
-
(2008)
J Clin Invest
, vol.118
, pp. 3051-3064
-
-
Kinkade, C.W.1
Castillo-Martin, M.2
Puzio-Kuter, A.3
Yan, J.4
Foster, T.H.5
Gao, H.6
-
56
-
-
33645772721
-
Characterization of the recombinant adenovirus vector AdYB-1: Implications for oncolytic vector development
-
Glockzin G, Mantwill K, Jurchott K, Bernshausen A, Ladhoff A, Royer HD, et al. Characterization of the recombinant adenovirus vector AdYB-1: implications for oncolytic vector development. J Virol 2006;80:3904-11.
-
(2006)
J Virol
, vol.80
, pp. 3904-3911
-
-
Glockzin, G.1
Mantwill, K.2
Jurchott, K.3
Bernshausen, A.4
Ladhoff, A.5
Royer, H.D.6
-
57
-
-
77958556510
-
Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability
-
pii: e12661
-
Law JH, Li Y, To K, Wang M, Astanehe A, Lambie K, et al. Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability. PLoS One 2010;5:pii: e12661.
-
(2010)
PLoS One
, vol.5
-
-
Law, J.H.1
Li, Y.2
To, K.3
Wang, M.4
Astanehe, A.5
Lambie, K.6
|